4//SEC Filing
Trius Therapeutics Inc 4
Accession 0001209191-13-030663
CIK 0001356857operating
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:53 PM ET
Size
4.9 KB
Accession
0001209191-13-030663
Insider Transaction Report
Form 4
Bartizal Ken
Chief Development Officer
Transactions
- Sale
Common Stock
2013-06-04$7.90/sh−2,000$15,800→ 97,300 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- [F2]Includes 373 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/13.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001356857
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 7:53 PM ET
- Size
- 4.9 KB